IGC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 31.48%

Insider Buying (Last 12 Months): $199,999.90

Insider Selling (Last 12 Months): $0.00

IGC Pharma Insider Trading History Chart

IGC Pharma Share Price & Price History

^$0.34

▲ +0.0089 (2.73%)

As of 03/13/2025 04:58 PM ET

Days: 30 | 90 | 365

IGC Pharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/25/2024	James P Moran	Director	Buy	588,235	$0.34	$199,999.90	942,402

SEC Filings (Institutional Ownership Changes) for IGC Pharma (NYSEMKT:IGC)

3.87% of IGC Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

IGC Pharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/17/2025	Squarepoint Ops LLC	125,966	$42K	0.0%	N/A	0.163%
2/14/2025	Northern Trust Corp	113,407	$38K	0.0%	+59.7%	0.146%
2/12/2025	Geode Capital Management LLC	669,685	$0.23M	0.0%	+19.0%	0.865%
11/20/2024	Virtu Financial LLC	123,060	$53K	0.0%	+164.7%	0.159%
11/16/2024	Geode Capital Management LLC	562,969	$0.24M	0.0%	+31.0%	0.744%
10/29/2024	Fullcircle Wealth LLC	103,443	$42K	0.0%	N/A	0.137%

Data available starting January 2016

IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.

Today's Range

Now: $0.34

$0.32

$0.34

50 Day Range

MA: $0.32

$0.27

$0.36

52 Week Range

Now: $0.34

Volume

214,616 shs

Average Volume

383,424 shs

Market Capitalization

$26.69 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.21

Who are the company insiders with the largest holdings of IGC Pharma?: IGC Pharma's top insider investors include:
James P Moran (Director)
Learn More about top insider investors at IGC Pharma.
Who are the major institutional investors of IGC Pharma?: IGC Pharma's top institutional shareholders include:
Geode Capital Management LLC — 0.86%
Squarepoint Ops LLC — 0.16%
Northern Trust Corp — 0.15%
Citadel Advisors LLC — 0.00%
Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of IGC Pharma stock.
Which institutional investors are selling IGC Pharma stock?: In the previous quarter, IGC stock was sold by these institutional investors:
Citadel Advisors LLC
Which institutional investors are buying IGC Pharma stock?: During the previous quarter, IGC stock was purchased by institutional investors including:
Squarepoint Ops LLC
Geode Capital Management LLC
Northern Trust Corp